Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.

MLA

Labbé, Vincent, et al. “Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.” JAMA Internal Medicine, vol. 183, no. 6, June 2023, pp. 520–31. EBSCOhost, https://doi.org/10.1001/jamainternmed.2023.0456.

APA

Labbé, V., Contou, D., Heming, N., Megarbane, B., Razazi, K., Boissier, F., Ait-Oufella, H., Turpin, M., Carreira, S., Robert, A., Monchi, M., Souweine, B., Preau, S., Doyen, D., Vivier, E., Zucman, N., Dres, M., Fejjal, M., Noel-Savina, E., … Mekontso Dessap, A. (2023). Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial. JAMA Internal Medicine, 183(6), 520–531. https://doi.org/10.1001/jamainternmed.2023.0456

Chicago

Labbé, Vincent, Damien Contou, Nicholas Heming, Bruno Megarbane, Keyvan Razazi, Florence Boissier, Hafid Ait-Oufella, et al. 2023. “Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.” JAMA Internal Medicine 183 (6): 520–31. doi:10.1001/jamainternmed.2023.0456.